Xenetic Biosciences- Warrants (19/07/2024) Current Cash

As of the most recent data (June 2026), XBIOW shows a current cash of $6.5M. That compares with $4.8M in the prior-year period — up 35.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, XBIOW's current cash is now $6.5M (was $4.8M) — a 35.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Xenetic Biosciences- Warrants (19/07/2024) is outperforming or lagging.

Tracking XBIOW's current cash over time shows whether Xenetic Biosciences- Warrants (19/07/2024) is scaling, shrinking, or reshaping that part of the business. The current reading is $6.5M That compares with $4.8M in the prior-year period — up 35.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Xenetic Biosciences- Warrants (19/07/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $6.5M) with ownership activity and broader fundamentals.

Xenetic Biosciences- Warrants (19/07/2024)'s current cash is $6.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.